Type of Study:

Study Design:

Outcome Measure:

Pathologic Complete Response

Outcome Description:

Pathologic complete response is defined as the disappearance of all invasive cancer in the postsurgical breast and lymph node specimens after completion of neoadjuvant chemotherapy. Only residual intraductal carcinoma in the postsurgical breast specimen after neoadjuvant chemotherapy is also considered as the achievement of pathologic complete response.

Outcome Time Frame:

26 weeks after the first administration of neoadjuvant chemotherapy with doxorubicin/cyclophosphamide regimens

Safety Issue:

No

Authority:

South Korea: Institutional Review Board

Study ID:

4-2011-0068

NCT ID:

NCT01660542

Start Date:

May 2011

Completion Date:

May 2016

Related Keywords:

Locally Advanced Breast Cancer

Breast Neoplasms

Name

Location

We are a Cancer Social Network, Resource Directory & Education Hub supporting all those affected by cancer. knowcancer.com is intended to be solely for informational purposes and should not be a substitute for professional medical advice, diagnosis or treatment.